Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Sees Large Increase in Short Interest

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) saw a large growth in short interest during the month of July. As of July 15th, there was short interest totalling 1,200 shares, a growth of 200.0% from the June 30th total of 400 shares. Based on an average daily volume of 3,700 shares, the days-to-cover ratio is currently 0.3 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Trading Down 1.3 %

NASDAQ HROWM traded down $0.33 on Friday, reaching $25.72. The company had a trading volume of 46,141 shares, compared to its average volume of 4,171. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a 52 week low of $22.71 and a 52 week high of $27.72. The stock’s 50 day moving average is $26.47 and its 200-day moving average is $26.21.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 31st. Shareholders of record on Monday, July 15th will be paid a dividend of $0.7422 per share. The ex-dividend date of this dividend is Monday, July 15th. This represents a $2.97 dividend on an annualized basis and a yield of 11.54%.

About Harrow Health, Inc. 11.875% Senior Notes due 2027

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.